JOURNAL OF COSMETIC SCIENCE 244 (44) G . Vanti, D. Bani, M. C. Salvatici, M. C. Bergonzi, and A. R. Bilia, Development and percutaneous permeation study of escinosomes, escin-based nanovesicles loaded with berberine chloride, Pharmaceu- tics, 11(12), 682 (2019). (45) M . L. Freile, F. Giannini, G. Pucci, A. Sturniolo, L. Rodero, O. Pucci, V. Balzareti, and R. D. Enriz, Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla, Fitote- rapia, 74, 702–705 (2003). (46) M . Cernáková and D. Kostálová, Antimicrobial activity of berberine -a constituent of Mahonia aquifo- lium, Folia Microbiol., 47(4), 375–378 (2002). (47) N. Zo r ić, I. Kosalec, S. Tomić, I. Bobnjarić, M. Jug, T. Vlainić, and J. Vlainić, Membrane of Candida albicans as a target of berberine, BMC Complement Altern. Med., 17, 268 (2017). (48) T. Seki an d M. Morohashi, Effect of some alkaloids, fl avonoids and triterpenoids, contents of Japanese- Chinese traditional herbal medicines, on the lipogenesis of sebaceous glands. Skin Pharmacol., 6(1), 56–60 (1993). (49) V. Aruna, G . V. Amruthavalli, and R. Gayathri, Use of cosmetic products for treating certain diseases- know the science, J. Cosmet. Dermatol., 18, 221–225 (2019). (50) T. S. Chan g , An updated review of tyrosinase inhibitors, Int. J. Mol. Sci., 10, 2440–2475 (2009). (51) C. L. Kuo, C. W. Chi, and T. Y. Liu, The anti-infl ammatory potential of berberine in vitro and in vivo, Cancer Lett., 203(2), 127–137 (2004). (52) A. S. Torky, M. S. Freag, M. M. Nasra, and O. Y. Abdallah, Novel skin penetrating berberine oleate complex capitalizing on hydrophobic ion pairing approach, Int J Pharm., 549(1-2), 76–86 (2018). (53) M. Zovko K o ncic, D. Kremer, K. Karlović, and I. Kosalec, Evaluation of antioxidant activities and phenolic content of Berberis vulgaris L. and Berberis croatica horvat, Food Chem . Toxicol., 48, 2176–2180 (2010). (54) N. Singh and B. Sharma, Toxicological effects of berberine and sanguinarine, Front Mol. Biosci., 5, 21 (2018). (55) K. Srinivasa n , Black pepper and its pungent principle-piperine: a review of diverse physiological effects, Crit. Rev. Food Sci. Nutr., 47, 735–748 (2007). (56) M. Nikolić, D . Stojaković, J. Glamočlija, A. Ćirić, T. Marković, M. Smiljković, and M. Soković, Could essential oils of green and black pepper be used as food preservatives, J. Food Sci. Technol., 52, 6565– 6573 (2015). (57) W. W. Epstein, D. F. N e tz, and J. L. Seidel, Isolation of piperine from black pepper, J. Chem. Educ., 70, 598–599 (1993). (58) B. Chopra, A. K. Dhing r a, R. P. Kapoor, and D. N. Prasad, Piperine, and its various physicochemical and biological aspects: a review, Open Chem J., 3, 75–96 (2016). (59) U.-H. Park, H.-S. Jeon g , E.-Y. Jo, T. Park, S. K. Yoon, E. J. Kim, J.-C. Jeong, and S.-J. Um, Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells, J. Agr Food Chem., 60, 3853–3860 (2012). (60) K. Platel and K. Sriniva s an, Infl uence of dietary spices and their active principles on pancreatic digestive enzymes in albino rats. Food Nahrung., 44(1), 42–46 (2000). (61) W. L. Low, K. Kenward, S. T. Britland, M. C. Amin, and C. Martin, Essential oils and metal ions as alternative antimicrobial agents: a focus on tea tree oil and silver. Int. Wound J., 14(2), 369–384 (2017). (62) S. Wadhwa, S. Singhal, an d S. Rawat, Bioavailability enhancement by piperine: a review, Asian J. Biomed. Pharm Sci., 4, 1–8 (2014). (63) P. B. Lalthanpuii, K. Lal c hhandama, R. Lalawmpuii, H. Lalhlenmawia, and K. Vanlaldinpuia, “Chemi- cal constituents and some biological properties of the traditional herbal medicine Acmella oleracea (As- teraceae),” in Book: Science and Technology for Shaping the Future of Mizoram (Allied Publishers, New Delhi, 2017), pp. 289–294. (64) P. B. Cruz, A. F. Barbos a, V. Zeringóta, D. Melo, T. Novato, Q. C. Fidelis, R. L. Fabri, M. G. de Carv- alho, A. U. O. Sabaa-Srur, E. Daemon, and C. M. O. Monteiro, Acaricidal activity of methanol extract of Acmella oleracea L. (Asteraceae) and spilanthol on Rh ipicephalus microplus (Acari: ixodidae) and Derma- centor nitens (Acari: ixodidae), Vet. Parasitol., 228, 137–143 (2016). (65) F. Demarne and G. Passaro, Use of an Acmella oleracea Extract for the Botulinum Toxin-Like Effect There of in an Anti-Wrinkle Cosmetic Composition, US Patent No. 7,531,193 B2 (2005). (66) L. Veryser, E. Wynendaele, L. Taevernier, F. Verbeke, T. Joshib, P. Tatke, and B. De Spiegeleer, N-alkylamides: from plant to brain, Func. Food Health Disease, 4(6), 264–275 (2014).

ALKALOIDS IN COSMETICS 245 (67) A. Mrozek-Szetela, Acmella oleracea – whether nature has an alternative to botox? Herbalism, 1, 84–100 (2015). (in Polish). (68) P. Bonner, A. D. Marzano, C . Kaminski, and K. A. Reynertson, Topical Compositions Comprising Ac- mella oleracea Extracts and Uses Thereof, US Patent No. 9,522,168 B2 (2014). (69) J. E. Castro-Ruiz, A. Roja s -Molina, F. J. Luna-Vázquez, F. Rivero-Cruz, T. García Gasca, and C. Ibarra- Alvarado, Affi nin (Spilanthol), isolated fro m heliops is longipes, induces vasodilation via activation of gasotransmitters and prostacyclin signaling pathways, Int. J. Mol. Sci., 18, 218–232 (2017). (70) J. Molina-Torres, C. J. Sala z ar-Cabrera, C. Armenta-Salinas, and E. Ramírez-Chávez, Fungistatic and bacteriostatic activities of alkamides from Heliopsis longipes ro ots: affi nin and reduced amides, J. Agric . Food Chem., 52(15), 4700–4704 (2004). (71) T. Thomas, D. T. Kanathkunn, a n d R. M. Sarveswara, Pharmaceutical, Dietary Supplement, and Food Grade Salts of Anatabine, US Patent No. 13/477, 295 (2012). (72) F. V. Rossi, R. Ballini, L. Ba r boni, P. Allegrini, and A. Palmieri, A practical and effi cient synthesis of anatabine, Synthesis, 5, 1921–1925 (2018). (73) J. R. Williams, Skin Care Prod u cts Containing Anatabine or Derivative Thereof, US Patent No. 13/803, 028 (2013). (74) D. Paris, D. Beaulieu-Abdelaha d , C. Bachmeier, J. Reed, G. Ait-Ghezala, A. Bishop, J. Chao, V. Mathura, F. Crawford, and M. Mullan, Anatabine lowers Alzheimer’s Aβ prod uction in vitro and in vivo, Eur. J. Pharmacol., 670, 384–391 (2011). (75) D. Paris, D. Beaulieu-Abdelahad, L. Abdullah, C. Bachmeier, G. Ait-Ghezala, J. Reed, M. Verma, F. Crawford, and M. Mullan, Anti-infl ammatory activity of anatabine via inhibition of STAT3 phosphory- lation, Eur. J. Pharmacol., 698, 145–153 (2013). (76) R. K. Lanier, A. E. Cohen, and S . H. Weinkle, Effects of a facial cream containing the minor alkaloid anatabine on improving the appearance of the skin in mild to moderate rosacea: an open-label case series study, Case Rep Dermatol., 5, 347–356 (2013). (77) K. B. Michels, W. C. Willett, C. S. Fuchs, and E. Giovannucci: Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer, J. Natl Cancer I, 97, 282–292 (2005). (78) C. Căruntu, C. Negrei, M. A. Ghi ţ ă, A. Căruntu, A. I. Bădărău, I. Buraga, D. Boda, A. Albu, and D. Brănişteanu, Capsaicin, a hot topic in skin pharmacology and physiology, Farmacia, 63, 487–491 (2015).